Arca
Skip to content

Lustre PRO Light System

Powered Laser Surgical Instrument. 510(k) K143713, from Ambicare Health, Ltd. (Livingston, GB). Product code GEX, class 2.

As of Nov 17, 2026, K143713 is an FDA 510(k) held by Ambicare Health, Ltd., substantially equivalent on Jan 19, 2016 after 386 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jan 19, 2016
  • Review time: 386 days
  • Recalls: 0
  • Cited as a predicate by: 1 device

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Lustre PRO light system is indicated for the treatment of mild to moderate acne.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF
  • Silkn BlueK121435 · Home Skinovations , Ltd. · Feb 22, 2013

Cited as a Predicate

1 later 510(k) summary names this device as a predicate

Other GEX Clearances

The newest 510(k)s for the same product code; their median review was 90 days; see every GEX device

Record

Type
Traditional
Received
Dec 29, 2014
Review panel
General, Plastic Surgery
Regulation
21 CFR 878.4810

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.